According to the news of Korea Biomedical Review, South Korea National Institute of Infectious Diseases (NIID) announced that it has started clinical research in cooperation with the US National Institute of Allergy and Infectious Diseases (NIAID) to prepare for infectious diseases that may arise.
In the clinical trial called “STRIVE”, it is planned to first examine newly developed antiviral and immunomodulatory drugs for COVID-19 patients.
Local hospitals and researchers will be able to participate in the clinical trials of STRIVE, which was announced to be started in preparation for a possible epidemic.
NIID Director Jang Hee-chang said, “We will continue our global clinical trial collaboration system with major clinical research centers around the world to strengthen our ability to develop new treatments for infectious diseases and respond to emerging infectious diseases alongside NIAID.” said.